ask="1.09"
ask_size="2200"
average_daily_volume="645180"
bid="N/A"
bid_size="N/A"
book_value="0.61"
change="-0.01"
change_from_200_day_moving_average="-0.94"
change_from_50_day_moving_average="-0.11"
change_from_52_week_high="-4.05"
change_From_52_week_low="0.38"
change_in_percent="-1.68%"
close="0.88"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.05"
ebitda="-8.78M"
eps_estimate_current_year="-1.12"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.32"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.93"
high_52_weeks="4.93"
last_trade_date="3/13/2017"
last_trade_price="0.88"
last_trade_size="333"
last_trade_time="4:00pm"
low="0.86"
low_52_weeks="0.50"
market_capitalization="6.28M"
moving_average_200_day="1.82"
moving_average_50_day="0.99"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="1.00"
open="0.92"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-51.52%"
percent_change_from_50_day_moving_average="-11.26%"
percent_change_from_52_week_high="-82.15%"
percent_change_from_52_week_low="+76.00%"
previous_close="0.89"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.48"
price_per_sales="2.50"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="1.06"
stock_exchange="NCM"
symbol="OPXA"
volume="133391"
weeks_range_52="0.50 - 4.93"
